The 5-Year Disease-Free Survival of Third Generation Aromatase Inhibitor for Postmenopausal Women with HR-Positive HER2-Negative Non-Metastatic Breast Cancer.

Etikasari, Ria; Andayani, Tri Murti; Endarti, Dwi; Taroeno-Hariadi, Kartika Widayati

Etikasari, Ria; Andayani, Tri Murti; Endarti, Dwi; Taroeno-Hariadi, Kartika Widayati.

Afiliación

Etikasari R; Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Andayani TM; Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Endarti D; Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Taroeno-Hariadi KW; Division of Hematology and Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.

Int J Hematol Oncol Stem Cell Res ; 17(1): 48-55, 2023 Jan 01.

Article en En | MEDLINE | ID: mdl-37638281

Palabras clave

Aromatase inhibitor; Breast cancer; Disease-free survival; HR-positive; Postmenopause

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Int J Hematol Oncol Stem Cell Res Año: 2023 Tipo del documento: Article País de afiliación: Indonesia Pais de publicación: Irán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google